| News Releases |
| Mar 8:
MDS Inc. Completes Divestiture of MDS Pharma Services Early Stage Business |
| Feb 19: MDS Announces Substantial Issuer Bid |
| Feb 10: MDS Announces Agreements to Divest MDS Pharma Services' Early Stage Business |
| Feb 01: MDS Inc. Completes Divestiture of MDS Analytical Technologies |
| Jan 27: MDS Receives U.S. Federal Trade Commission Provisional Regulatory Approval for Sale of MDS Analytical Technologies |
| Jan 25: MDS Announces Resolution of Litigation Related to the Sale of MDS Analytical Technologies |
| Jan 08: MDS Appoints Steve West MDS Inc. Chief Executive Officer |
| Dec 11: MDS Receives Notice of Application from PerkinElmer, Inc |
| Nov 03: MDS Inc. and Danaher Corporation Receive Second Request for Information from U.S. Federal Trade Commission for MDS Analytical Technologies Sale |
| Nov 02: MDS Inc. Completes Divestiture of Central Labs Operations |
| Sept 02: MDS Announces Strategic Repositioning |
| Sept 02: MDS Announces Voting Support Agreements |
| Sept 04: MDS Announces Special Meeting of Shareholders and Record Date |
| Sept 17: MDS Announces CEO Transition Plan |
| Sept 24: MDS Files Management Proxy Circular |
| Oct 08 : Leading Proxy Advisory Firms Recommend that MDS Shareholders Vote for the Divestiture of MDS Analytical Technologies |
| Oct 09 : MDS Announces Agreement to Sell Central Labs Operation to Czura Thornton |
| Oct 20 : MDS Inc. Announces Shareholder Approval of Sale of MDS Analytical Technologies |
| Additional Information |
| - Strategic Repositioning of MDS |
| - Management Proxy Circular |
| - Frequently Asked Questions |
| Photography |
| -
William D. Anderson, Chairman, Board of Directors |
jpg |
| - Steve M. West - Chief Executive Officer, MDS Inc., President, MDS Nordion. |
jpg |
| Media Contacts |
| Janet Ko, MDS Inc.: 905.267.4226, E-mail: janet.ko@mdsinc.com |
| |
| News Releases |
| Jul 8, 2009:
MDS Nordion Continues to Urge Government of Canada to Complete MAPLE Project to Address Critical Medical Isotope Shortage |
| Jun 1, 2009: MDS Nordion Urges Government of Canada to Complete MAPLE Project to Address Current Medical Isotope Supply Shortage |
| May 19, 2009: MDS Nordion Provides Update on AECL's Medical Isotope Supply Disruption |
| May 4, 2009: MDS Nordion, TRIUMF and the University of British Columbia Announce Partnership to Develop New Diagnostic Imaging Agents |
| Apr 28, 2009: MDS Nordion and TRIUMF Collaborate to Study Development of Photo Fission-Produced Molybdenum-99 |
| Standing Committee on Natural Resources |
| October 19, 2009: Steve West’s Opening Remarks to Standing Committee on Natural Resources |
| June 11, 2009: MDS Nordion Opening Remarks to the Standing Committee on Natural Resources |
| Opinion & Editorial |
| Preserving Canada's Leadership in Medical Isotope Supply |
| Article |
| Nuclear Engineering International |
| Backgrounders |
| *NEW* - The MAPLE Project: A Safe Viable Way to Produce Isotopes |
| Medical Isotope Solutions |
| MAPLE Project Key Dates |
| Medical Isotopes and MDS Nordion |
| Media Contacts |
| Shelley Maclean, MDS Nordion: 613.592.3400, ext. 2414, E-mail: shelley.maclean@mdsinc.com |
| |
